Moderna, Inc. Total Assets

Quick Answer

Moderna, Inc. reported Total Assets of $12.34 billion for fiscal year 2025.

Moderna, Inc. Total Assets — Annual History

Fiscal Year Total Assets YoY Change
2025 $12.34B -12.8%
2024 $14.14B -23.2%
2023 $18.43B -28.7%
2022 $25.86B +4.8%
2021 $24.67B +236.2%
2020 $7.34B +361.6%
2019 $1.59B -19.0%
2018 $1.96B +80.9%
2017 $1.08B

Quarterly Total Assets

Quarter Ending Total Assets YoY QoQ
September 30, 2025 $12.13B -23.2% +1.0%
June 30, 2025 $12.01B -23.4% -5.5%
March 31, 2025 $12.70B -24.1% -10.2%
December 31, 2024 $14.14B -23.2% -10.5%
September 30, 2024 $15.80B -18.8% +0.8%
June 30, 2024 $15.68B -28.3% -6.3%
March 31, 2024 $16.73B -30.7% -9.2%
December 31, 2023 $18.43B -28.7% -5.3%
  • Moderna, Inc. showed a decrease of -12.8% in Total Assets compared to the prior fiscal year.
  • Over the 2017–2025 period, Moderna, Inc.’s total assets has grown by 1037.7% (from $1.08 billion to $12.34 billion).
  • The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment